Functional neuroimaging in Alzheimer's type dementia

Journal of the Neurological Sciences

Volumn 203-204, Issue , 2002, Pages 247-251

  Demetriades, Andreas K ^a,b  

^a TRINITY COLLEGE   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Alzheimer's disease; Early diagnosis; Fluorodeoxyglucose (FDG); Functional imaging; Positron emission tomography (PET)

Indexed keywords

FLUORODEOXYGLUCOSE;

ALZHEIMER DISEASE; CONFERENCE PAPER; DIAGNOSTIC ACCURACY; DISEASE COURSE; DISEASE SEVERITY; GLUCOSE METABOLISM; HUMAN; NEUROPSYCHIATRY; NEUROPSYCHOLOGICAL TEST; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

AGED; ALZHEIMER DISEASE; CEREBRAL CORTEX; DISEASE PROGRESSION; HUMANS; MAGNETIC RESONANCE IMAGING; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0037111311     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(02)00299-X     Document Type: Conference Paper

References (19)

1. Braak H., Braak E. Staging of Alzheimer's disease-related neurofibrillary changes. Neurobiol. Ageing. 16(3):1995;271-278. [discussion 278-284].
2. Samuel W., Terry R.D., DeTeresa R., Butters N., Masliah E. Clinical correlates of cortical and nucleus basalis pathology in Alzheimer dementia. Arch. Neurol. 51(8):1994;772-778.
3. Friedland R.P., Brun A., Budinger T.F. Pathological and positron emission tomographic correlations in Alzheimer's disease. Lancet. 1(8422):1985;228. [letter].
4. Mielke R., Schroder R., Fink G.R., Kessler J., Herholz K., Heiss W.D. Regional cerebral glucose metabolism and postmortem pathology in Alzheimer's disease. Acta Neuropathol. Berl. 91(2):1996;174-179.
5. Minoshima S., Frey K.A., Koeppe R.A., Foster N.L., Kuhl D.E. A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. J. Nucl. Med. 36(7):1995;1238-1248.
6. Vander Borght T., Minoshima S., Giordani B., Foster N.L., Frey K.A., Berent S.et al. Cerebral metabolic differences in Parkinson's and Alzheimer's diseases matched for dementia severity. J. Nucl. Med. 38(5):1997;797-802.
7. Minoshima S., Giordani B., Berent S., Frey K.A., Foster N.L., Kuhl D.E. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease. Ann. Neurol. 42(1):1997;85-94.
8. Small G.W., Komo S., La-Rue A., Saxena S., Phelps M.E., Mazziotta J.C.et al. Early detection of Alzheimer's disease by combining apolipoprotein E and neuroimaging. Ann. N.Y. Acad. Sci. 16(802):1996;70-78.
9. Reiman E.M., Caselli R.J., Yun L.S., Chen K., Bandy D., Minoshima S.et al. Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. N. Engl. J. Med. 334(12):1996;752-758.
10. Rossor M.N., Kennedy A.M., Frackowiak R.S. Clinical and neuroimaging features of familial Alzheimer's disease. Ann. N.Y. Acad. Sci. 777:1996;49-56.
11. Burdette J.H., Minoshima S., Vander-Borght T., Tran D.D., Kuhl D.E. Alzheimer disease: improved visual interpretation of PET images by using three-dimensional stereotaxic surface projections. Radiology. 198(3):1996;837-843.
12. Scheltens P., Barkhof F., Leys D., Wolters E.C., Ravid R., Kamphorst W. Histopathologic correlates of white matter changes on MRI in Alzheimer's disease and normal aging. Neurology. 45(5):1995;883-888.
13. DeCarli C., Grady C.L., Clark C.M., Katz D.A., Brady D.R., Murphy D.G.et al. Comparison of positron emission tomography, cognition, and brain volume in Alzheimer's disease with and without severe abnormalities of white matter. J. Neurol. Neurosurg. Psychiatry. 60(2):1996;158-167.
14. Xanthakos S., Krishnan K.R., Kim D.M., Charles H.C. Magnetic resonance imaging of Alzheimer's disease. Prog. Neuropsychopharmacol. Biol. Psychiatry. 20(4):1996;597-626.
15. Laakso M.P., Partanen K., Riekkinen P., Lehtovirta M., Helkala E.L., Hallikainen M.et al. Hippocampal volumes in Alzheimer's disease, Parkinson's disease with and without dementia, and in vascular dementia: an MRI study. Neurology. 46(3):1996;678-681.
16. Kesslak J.P., Nalcioglu O., Cotman C.W. Quantification of magnetic resonance scans for hippocampal and parahippocampal atrophy in Alzheimer's disease. Neurology. 41(1):1991;51-54.
17. Chandrasekaran K., Hatanpaa K., Brady D.R., Rapoport S.I. Evidence for physiological down-regulation of brain oxidative phosphorylation in Alzheimer's disease. Exp. Neurol. 142(1):1996;80-88.
18. Murphy D.G., Bottomley P.A., Salerno J.A., DeCarli C., Mentis M.J., Grady C.L.et al. An in vivo study of phosphorus and glucose metabolism in Alzheimer's disease using magnetic resonance spectroscopy and PET. Arch. Gen. Psychiatry. 50(5):1993;341-349.
19. Silverman D.H., Small G.W., Chang C.Y., Lu C.S., Kung De Aburto M.A., Chen W.et al. Positron emission tomography in evaluation of dementia: regional brain metabolism and long-term outcome. JAMA. 286(17):2001;2120-2127.